precarious financials

Revised new contribs means company desperate to raise cash for survival.(to pay for new tomsk plant is rubbish).

They have virtually no sales otherwise the so called financial forecasts would be resulting in profits of $40 million PLUS ON A YEARLY BASIS(as dollar low 60c/USD)..

Technically they are out of cash now...spending approx $1m /qtr and that is why option sweetener -- to lure in suckers and the time delay so as to meet ASIC lodgement rules.

Why do they need option exercise money in two years time???? supposedly THEY ARE WORLD BEATERS AND EARNING MILLIONS AND MILLIONS IN REVENUES?????????? something definitely does not stack up.
Supposed cash forecasts may be right in ten years time -- but supply constrained ????dubious... where are the sales that supposedly could internally fund all these projects...NOWHERE ANY SHAREHOLDER CAN SEE OR HAS BEEN TOLD ABOUT.

INDEPENDENT DIRECTORS REQUIRED.


Bioprospect, an unnecessary diversion of energy and SLA funds, a total misjudgement.... especially as other biotech companies have FAR better statistical animal health results --- (ASX -- STI). The BPO stake can only be for the horse results.

A QUESTION FOR SHAREHOLDERS---DO YOU FEEL YOU ARE BEING KEPT IN THE DARK...

Remember these directors track record of being unable to understand contracts or not bothering to reading them.Imagine putting up the controlling stake of a company into such a venture and losing it.. OPES OPES -- tick done

Inspiring stuff .... whose being diluted ????